Modelling of onchocerciasis-associated skin and ocular disease and the impact of ivermectin treatment
Integrating morbidity outcomes into transmission dynamics modelling will help improve estimates of onchocerciasis disease burden and inform the effectiveness and cost-effectiveness of current and alternative interventions.
Authors
- Matthew A. Dixon (ORCID: https://orcid.org/0000-0002-1710-6237)
- Jacob N. Stapley (ORCID: https://orcid.org/0000-0003-0732-1600)
- Aditya Ramani
- Jonathan F Mosser
- Ian E Murdoch
- Gladys A. Ozoh
- Michele E. Murdoch
- Martin Walker
- Maria-Gloria Basáñez
Institutions
- Royal Veterinary College (GB)
- West Hertfordshire Hospitals NHS Trust (GB)
- Institute for Health Metrics and Evaluation (US)
- Seattle Children's Hospital (US)
- London Centre for Neglected Tropical Disease Research (GB)
- University of Nigeria Teaching Hospital (NG)
- Imperial College London (GB)
Publication Details
- Journal
- Communications Medicine
- Published
- 2026-03-02
- DOI
- https://doi.org/10.1038/s43856-026-01464-2
- Primary Topic
- Parasitic Diseases Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bill and Melinda Gates Foundation
- Medical Research Council
- European and Developing Countries Clinical Trials Partnership